Protagonist Therapeutics, Inc. (PTGX)
NASDAQ: PTGX · Real-Time Price · USD
146.92
-0.83 (-0.56%)
Sep 1, 2026, 12:40 PM EDT - Market open
Protagonist Therapeutics Market Cap
Protagonist Therapeutics has a market cap or net worth of $9.51 billion as of September 1, 2026. Its market cap has increased by 158.79% in one year.
Market Cap
9.51B
Enterprise Value
8.67B
1-Year Change
158.79%
Ranking
Category
Stock Price
$146.92
ChartMarket Cap Chart
Since August 11, 2016, Protagonist Therapeutics's market cap has increased from $171.50M to $9.51B, an increase of 5,443.41%. That is a compound annual growth rate of 49.03%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 1, 2026 | 9.51B | 74.12% |
| Dec 31, 2025 | 5.46B | 137.34% |
| Dec 31, 2024 | 2.30B | 73.94% |
| Dec 29, 2023 | 1.32B | 146.39% |
| Dec 30, 2022 | 536.80M | -67.11% |
| Dec 31, 2021 | 1.63B | 111.63% |
| Dec 31, 2020 | 771.30M | 302.14% |
| Dec 31, 2019 | 191.80M | 17.81% |
| Dec 31, 2018 | 162.80M | -61.78% |
| Dec 29, 2017 | 426.00M | 15.89% |
| Dec 30, 2016 | 367.60M | 114.34% |
| Aug 11, 2016 | 171.50M | - |
View and export this data all the way back to 2016. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Krystal Biotech | 10.64B |
| ABIVAX Société Anonyme | 10.60B |
| Axsome Therapeutics | 10.40B |
| Apogee Therapeutics | 10.19B |
| Ionis Pharmaceuticals | 10.03B |
| Kymera Therapeutics | 9.88B |
| Cytokinetics | 9.86B |
| Praxis Precision Medicines | 9.78B |